Prognostic impact of blood product transfusion in VA and VV ECMO.
Guillaume GuimbretièreAmedeo AnselmiAntoine RoisneBernard LelongHervé CorbineauThierry LanganayErwan FlécherJean-Philippe VerhoyePublished in: Perfusion (2018)
An ECMO program is associated with important consumption of blood products. VA ECMO patients have a greater transfusion burden than VV ECMO patients. Mortality is greater in the case of extreme transfusion requirements.
Keyphrases
- extracorporeal membrane oxygenation
- end stage renal disease
- acute respiratory distress syndrome
- ejection fraction
- newly diagnosed
- chronic kidney disease
- cardiac surgery
- prognostic factors
- type diabetes
- respiratory failure
- risk factors
- cardiovascular disease
- sickle cell disease
- intensive care unit
- coronary artery disease
- quality improvement